J. M. Robinson

The efficacy and safety of a new enteric-coated formulation of fluoxetine given once weekly during the continuation treatment of major depressive disorder.

M. Fava, R. Judge, M. Schmidt, 2000, The Journal of clinical psychiatry.

Immunomodulation in Type 1 Diabetes by NBI‐6024, an Altered Peptide Ligand of the Insulin B(9−23) Epitope

R. Maki, P. Gottlieb, A. Putnam, 2006, Scandinavian journal of immunology.

Successful discontinuation of insulin treatment after gestational diabetes is shown to be a case of MODY due to a glucokinase mutation

S. Ellard, D. Tymms, S. Kalavalapalli, 2008 .

Patient compliance to a new enteric-coated weekly formulation of fluoxetine during continuation treatment of major depressive disorder.

A. Claxton, M. Schmidt, J. M. Robinson, 2000, The Journal of clinical psychiatry.